Page last updated: 2024-09-03

bay x 1005 and n-formylmethionine leucyl-phenylalanine

bay x 1005 has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies

Compound Research Comparison

Studies
(bay x 1005)
Trials
(bay x 1005)
Recent Studies (post-2010)
(bay x 1005)
Studies
(n-formylmethionine leucyl-phenylalanine)
Trials
(n-formylmethionine leucyl-phenylalanine)
Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine)
58686,71653356

Protein Interaction Comparison

ProteinTaxonomybay x 1005 (IC50)n-formylmethionine leucyl-phenylalanine (IC50)
fMet-Leu-Phe receptorHomo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fruchtmann, R; Hatzelmann, A; Mohrs, KH; Müller-Peddinghaus, R; Raddatz, S1

Other Studies

1 other study(ies) available for bay x 1005 and n-formylmethionine leucyl-phenylalanine

ArticleYear
Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4.
    Biochemical pharmacology, 1994, Jul-05, Volume: 48, Issue:1

    Topics: Calcimycin; Cell Degranulation; Humans; In Vitro Techniques; Leukotriene B4; Lipoxygenase Inhibitors; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Quinolines

1994